## **Core Concept**
Congenital myopathies are a group of **genetic neuromuscular disorders** present at birth, characterized by muscle weakness and distinct histopathological features. They are caused by mutations in various genes that encode proteins crucial for muscle function. These disorders are distinct from other myopathies due to their congenital onset and specific pathological changes.

## **Why the Correct Answer is Right**
The correct answer, , refers to **Pompe disease**, also known as Glycogen storage disease type II. While Pompe disease is indeed a genetic disorder affecting muscle function, it is primarily classified as a **lysosomal storage disease** rather than a congenital myopathy. It results from the deficiency of **acid alpha-glucosidase** (GAA), leading to accumulation of glycogen in lysosomes. This distinction makes it different from the classic congenital myopathies, which include conditions like nemaline myopathy, central core disease, and multicore-multiminicore disease.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This likely refers to a condition like **nemaline myopathy**, characterized by the presence of nemaline bodies (or rods) in muscle fibers. It is a classic example of a congenital myopathy.
- **Option B:** - This could refer to **centronuclear myopathy**, another form of congenital myopathy with characteristic nuclear positioning in muscle fibers.
- **Option D:** - This might refer to **multicore-multiminicore disease**, also a type of congenital myopathy with distinctive pathological features.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is to recognize that while Pompe disease (Glycogen storage disease type II) affects muscles and has some overlapping clinical features with congenital myopathies, its underlying pathophysiology as a lysosomal storage disorder sets it apart. This distinction is crucial for diagnosis and management.

## **Correct Answer:** . Pompe disease